Question 1

What is the catalog number for N'-Hydroxy-1- (1,3-thiazol-2-yl) -1H-pyrrole-2-carboximidamide?

Accepted Answer

The catalog number for N'-Hydroxy-1- (1,3-thiazol-2-yl) -1H-pyrrole-2-carboximidamide is sc-331553.

Question 2

What sizes are available for N'-Hydroxy-1- (1,3-thiazol-2-yl) -1H-pyrrole-2-carboximidamide?

Accepted Answer

N'-Hydroxy-1- (1,3-thiazol-2-yl) -1H-pyrrole-2-carboximidamide is available in the following size(s): 1 mg.

Question 3

Is N'-Hydroxy-1- (1,3-thiazol-2-yl) -1H-pyrrole-2-carboximidamide in stock?

Accepted Answer

N'-Hydroxy-1- (1,3-thiazol-2-yl) -1H-pyrrole-2-carboximidamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

N'-Hydroxy-1- (1,3-thiazol-2-yl) -1H-pyrrole-2-carboximidamide

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Anti-Caspase-7 Casp7 Rabbit Monoclonal Antibody, Carrier-free

Anti-NUDCD3 Antibody Picoband®, Dylight550 Conjugate

Calcineurin B / PPP3R1 (BE2.1), 0.2mg/mL

Anti-MUC4 Antibody Picoband® (Biotine Conjugate)

CD34 (HPCA1/1171), CF640R conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2744), CF568 conjugate, 0.1mg/mL